Akkermansia muciniphila CAG:154

Information

Microbe Identification

Akkermansia muciniphila CAG:154

Microbe id: PMDBM2021777
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Akkermansia muciniphila CAG:154 [1263034]
Taxonomy Genus: Akkermansia [239934]
Taxonomy Family: Akkermansiaceae [1647988]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Akkermansia muciniphila CAG:154

No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Akkermansia muciniphila CAG:154


No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Akkermansia muciniphila CAG:154 distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Akkermansia muciniphila CAG:154 in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Akkermansia muciniphila CAG:154

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJEB65297🔗3.97146715006226mNGS
Hypertension PRJNA509999🔗4.1888953299838mNGS
Arthritis, Juvenile PRJNA562467🔗-3.9273737122753516S
Diarrhea PRJEB14038🔗-4.43491818736759mNGS
Diarrhea PRJNA317326🔗-4.263527114931616S
Colorectal Neoplasms PRJNA731589🔗-3.81064543575052mNGS
Colorectal Neoplasms PRJNA698923🔗3.7121209371752316S
Colorectal Neoplasms PRJEB53415🔗4.0261110674673416S
Hepatitis, Autoimmune PRJNA556801🔗4.2642392334898616S
Colitis, Ulcerative PRJNA804422🔗-4.1145729685530516S
Colitis, Ulcerative PRJNA398089🔗-3.9078365014109mNGS
Colitis, Ulcerative PRJNA993675🔗-3.85559021427584mNGS
Colitis, Ulcerative PRJNA820056🔗2.7656698900470416S
Campylobacter Infections PRJNA660443🔗-3.93813205398036mNGS
Spinal Cord Injuries PRJNA861246🔗-3.9529477438905216S
Non-alcoholic Fatty Liver Disease PRJNA851946🔗-3.8858480084438716S
Crohn Disease PRJNA993675🔗-3.84469555858088mNGS
Crohn Disease PRJNA398089🔗-3.82979050171354mNGS
Crohn Disease PRJNA793776🔗-3.73629015979891mNGS
Crohn Disease PRJNA1156939🔗3.8665053077008916S
Polycystic Ovary Syndrome PRJEB38647🔗-3.5266860455362116S
Diabetic Retinopathy PRJNA646010🔗4.0776192842017316S
Dermatitis, Atopic PRJEB45443🔗-4.25089783455439mNGS
Arthritis, Rheumatoid PRJNA574565🔗-3.2547009723765616S
Arthritis, Rheumatoid PRJNA786110🔗3.9923035089244816S
Growth Hormone-Secreting Pituitary Adenoma PRJNA743650🔗2.8002337406108816S
Anorexia Nervosa PRJEB11199🔗4.1375993893540716S
Neuroblastoma PRJEB63351🔗3.73889732591559mNGS
Hematologic Neoplasms PRJNA777832🔗-4.0508700208113216S
Irritable Bowel Syndrome PRJEB37924🔗-4.14987028772653mNGS
Irritable Bowel Syndrome PRJNA705217🔗3.7019538883186mNGS
Depressive Disorder, Major PRJNA762199🔗4.23780194401917mNGS
Clostridium Infections PRJNA648321🔗-3.7741804756723mNGS
Alzheimer Disease PRJEB51982🔗-4.3463930557635416S
Alzheimer Disease PRJEB59009🔗-3.2571826308147716S
Liver Cirrhosis PRJNA861246🔗-3.7825906625489716S
Liver Cirrhosis PRJNA872871🔗4.4472113425595816S
Cystic Fibrosis PRJNA314903🔗-4.32057349665385mNGS
HIV Infections PRJNA810567🔗4.0289584775476716S
Neuromyelitis Optica PRJNA662563🔗2.4024919186566916S
Inflammatory Bowel Diseases PRJNA511372🔗-3.85776909073594mNGS
Hand, Foot and Mouth Disease PRJNA1017976🔗4.7593044319201916S
Renal Insufficiency, Chronic PRJEB65297🔗3.61994369601977mNGS
Renal Insufficiency, Chronic PRJNA562327🔗4.1008274674498316S
Fibromyalgia PRJNA521587🔗3.82740890462697mNGS
COVID-19 PRJNA769052🔗-4.6830160918070716S
COVID-19 PRJNA689961🔗3.83447193785011mNGS
COVID-19 PRJNA678695🔗3.9743493757116816S

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Akkermansia muciniphila CAG:154



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Akkermansia muciniphila CAG:154



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Akkermansia muciniphila CAG:154

No data available!

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
No records found

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Akkermansia muciniphila CAG:154


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Akkermansia muciniphila CAG:154



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Akkermansia muciniphila CAG:154

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Akkermansia muciniphila CAG:154

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Akkermansia muciniphila CAG:154

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Akkermansia muciniphila CAG:154



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Akkermansia muciniphila CAG:154


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Akkermansia muciniphila CAG:154


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?